How should I evaluate and treat a 67-year-old woman presenting with frontal hairline recession and eyebrow loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Frontal Fibrosing Alopecia: Evaluation and Treatment

This 67-year-old woman most likely has frontal fibrosing alopecia (FFA), and you should start intralesional triamcinolone acetonide injections immediately while adding low-dose oral minoxidil 1 mg daily to improve cosmetic coverage.

Initial Diagnostic Approach

Look specifically for these clinical features that confirm FFA:

  • Frontotemporal hairline recession (present in 100% of cases) 1
  • Eyebrow loss - complete or partial (occurs in 81% of patients) 1
  • Perifollicular erythema (73% of cases) and perifollicular hyperkeratosis (31%) 1
  • Ask about pruritus, burning, or pain (65% report symptoms, though 35% are asymptomatic) 1

Perform dermoscopy/trichoscopy to assess disease activity by examining peripilar cast thickness - thicker casts correlate directly with more severe lymphocytic inflammation and active disease 2. This is critical because it guides treatment intensity without requiring biopsy.

Screen for autoimmune connective tissue diseases (present in 14% of FFA patients) 1 and check if she has associated lichen planus pigmentosus or rosacea, as these respond particularly well to certain treatments 3.

Treatment Algorithm

First-Line: Intralesional Corticosteroids

Start with intralesional triamcinolone acetonide - this achieved symptom reduction and hairline stabilization in 97% of treated FFA patients 1. This is your most evidence-based intervention.

  • Use triamcinolone acetonide 5-10 mg/mL 4
  • Inject just beneath the dermis in the upper subcutis 4
  • Use 0.05-0.1 mL per injection site (produces hair growth tuft ~0.5 cm diameter) 4
  • Target both the receding hairline AND eyebrows - this method is particularly suitable for cosmetically sensitive sites like eyebrows 4
  • Repeat monthly initially 4

The major limitation is patient discomfort from multiple injections 4, but the efficacy justifies this approach. Importantly, 31% of patients achieved remission lasting 6 months to 6 years after stopping treatment 1.

Add Low-Dose Oral Minoxidil for Cosmetic Improvement

Simultaneously start oral minoxidil 1 mg daily 5, 6. This is particularly important because:

  • FFA involves the entire scalp, making oral formulation preferred over topical 5
  • In a prospective FFA study, all 10 completers showed improvement in at least one area, with 9 of 10 showing increased anterior hairline coverage and 4 of 8 showing eyebrow improvement 6
  • Minoxidil has antifibrotic properties that inhibit fibroblast proliferation and lysyl hydroxylase - directly relevant to cicatricial alopecias like FFA 5
  • It's well-tolerated (mild hypertrichosis occurred in 50% but was acceptable) 6

Consider Adding Doxycycline

If she has associated lichen planus pigmentosus or rosacea, add doxycycline 100 mg daily 3. In a recent 2026 study of 50 FFA patients, doxycycline led to improvement in 57% overall, with particular efficacy when these conditions coexist 3. Dermoscopic improvements included decreased perifollicular erythema and hyperkeratosis 3.

Alternative for Severe/Refractory Cases

For younger patients or those with highly active disease not responding to the above, combination therapy with dutasteride, tofacitinib, and intralesional triamcinolone showed significant improvement in a 2026 case report 7. However, this is reserved for refractory cases given the more complex side effect profile.

Critical Pitfalls to Avoid

Do not delay treatment. FFA is progressive and results in permanent follicular destruction 8. Early intervention is essential - the 2014 study specifically concluded that "early intervention and treatment with intralesional triamcinolone acetonide may halt the progression of the disease" 1.

Do not use topical corticosteroids alone. While topical steroids like clobetasol propionate are used for alopecia areata 4, intralesional injection is the evidence-based approach for FFA 1.

Do not expect hair regrowth within 3 months - counsel her that response takes time 4.

Monitor for the one serious adverse event: One patient in the minoxidil FFA study discontinued due to a transient ischemic attack 6, though causality is unclear. Check baseline blood pressure and cardiovascular risk factors before starting minoxidil.

Monitoring Disease Activity

Use trichoscopy at follow-up visits to assess peripilar cast thickness - this noninvasive technique correlates strongly with inflammatory activity and guides treatment adjustments 2. Decreasing cast thickness, perifollicular erythema, and hyperkeratosis indicate treatment response 3.

References

8
Research

Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide.

Clinical, cosmetic and investigational dermatology, 2020

Related Questions

Does this patient need treatment for a minor unilateral frontal-temporal hair recession?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What is the optimal treatment regimen for primary central nervous system lymphoma in a patient receiving a direct oral anticoagulant, considering potential renal impairment?
What is the prodrome of trigeminal nerve herpes zoster?
How should I manage a patient with leukopenia (total leukocyte count 4,000/µL), thrombocytopenia (platelet count 70,000/µL), anemia (hemoglobin 8 g/dL) and multilobar bilateral multifocal consolidation on chest imaging?
In a patient with chronic liver disease presenting with unexplained dyspnea, platypnea‑orthodeoxia, or fingertip cyanosis, how should hepatopulmonary syndrome be diagnosed and managed?
Should vitamin B12 be administered orally as tablets for a patient with low serum B12 and markedly elevated homocysteine levels?
In a 9‑year‑old child with a direct (conjugated) bilirubin of 0.62 mg/dL and an aspartate aminotransferase (AST) of 37 IU/L, what does this indicate and what are the recommended next evaluation and management steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.